News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
830,050 Results
Type
Article (85544)
Company Profile (744)
Press Release (743762)
Section
Business (232227)
Career Advice (4102)
Deals (39640)
Drug Delivery (114)
Drug Development (90622)
Employer Resources (194)
FDA (17974)
Job Trends (17268)
News (395520)
Policy (39615)
Tag
Academia (2975)
Alliances (56413)
Alzheimer's disease (1326)
Approvals (17870)
Artificial intelligence (146)
Bankruptcy (394)
Best Places to Work (12473)
Biotechnology (507)
Breast cancer (120)
Cancer (1052)
Career advice (3510)
Cell therapy (243)
Clinical research (71283)
Collaboration (369)
Compensation (180)
COVID-19 (2796)
C-suite (95)
Data (969)
Diabetes (156)
Diagnostics (6655)
Drug pricing (101)
Earnings (94414)
Employer resources (167)
Events (126411)
Executive appointments (271)
FDA (18463)
Funding (324)
Gene therapy (177)
GLP-1 (685)
Government (5043)
Healthcare (20706)
Infectious disease (2884)
Inflammatory bowel disease (115)
Interviews (807)
IPO (17570)
Job creations (5178)
Job search strategy (2853)
Layoffs (485)
Legal (10039)
Lung cancer (176)
Manufacturing (184)
Medical device (14390)
Medtech (14395)
Mergers & acquisitions (22079)
Metabolic disorders (444)
Neuroscience (1600)
NextGen Class of 2024 (7656)
Non-profit (5063)
Northern California (1341)
Obesity (261)
Opinion (241)
Patents (105)
People (64064)
Pharmaceutical (147)
Phase I (21928)
Phase II (30943)
Phase III (23351)
Pipeline (327)
Postmarket research (3539)
Preclinical (9916)
Radiopharmaceuticals (256)
Rare diseases (214)
Real estate (7371)
Regulatory (25895)
Research institute (2640)
Resumes & cover letters (648)
Southern California (1204)
Startups (4274)
United States (13407)
Vaccines (645)
Weight loss (215)
Date
Today (264)
Last 7 days (1132)
Last 30 days (3587)
Last 365 days (38456)
2024 (33718)
2023 (42566)
2022 (53928)
2021 (58726)
2020 (57671)
2019 (51341)
2018 (39125)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1265)
Arizona (224)
Asia (49266)
Australia (8678)
California (3141)
Canada (1225)
China (236)
Colorado (138)
Connecticut (149)
Europe (112804)
Florida (428)
Georgia (115)
Illinois (396)
Indiana (207)
Kansas (103)
Maryland (596)
Massachusetts (2618)
Michigan (165)
Minnesota (282)
New Jersey (919)
New York (916)
North Carolina (813)
Northern California (1341)
Ohio (139)
Pennsylvania (805)
South America (1647)
Southern California (1204)
Texas (447)
Washington State (376)
There are 830,050 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
iSpecimen Named Top Competitor in $4.4 Billion USD Market
Biospecimen Market To Exceed $13.5 Billion USD By 2032
November 8, 2024
·
4 min read
Alzheimer’s disease
Eisai Cuts Fiscal 2024 Guidance for Biogen-Partnered Leqembi as Sales Disappoint Analysts
Leqembi’s sales continue to be underwhelming, according to analysts, who contend the companies’ Alzheimer’s disease therapy is being held back by barriers such as coverage, infusion centers and time to diagnosis.
November 8, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Kiora Pharmaceuticals Reports Third Quarter Results; Retinal Disease Pipeline Advancing Two Phase 2 Studies
November 8, 2024
·
11 min read
Editorial
Lilly vs. Novo: The ‘He Said, She Said’ Row About Catalent’s GLP-1 Work
With Novo Holdings’ $16.5 billion buyout of Catalent being reviewed by regulators, what work the contract drug manufacturer may or may not be performing for Eli Lilly remains a point of contention.
November 8, 2024
·
4 min read
·
Greg Slabodkin
Press Releases
SystImmune, Inc. Announces FDA Clearance of IND Application for BL-M17D1 in Advanced Solid Tumors
November 8, 2024
·
3 min read
Press Releases
BriaCell Showcases Robust Anti-Cancer Activity of Personalized Off-the-Shelf Immunotherapy Pipeline at the 2024 SITC Conference
November 8, 2024
·
7 min read
China
AstraZeneca’s China Head Taken Into Custody by Chinese Authorities: Reports
While it remains unclear why AstraZeneca China President Leon Wang has been detained, news of his arrest comes just days after it was reported that he was under investigation for alleged medical insurance fraud in the country.
November 8, 2024
·
2 min read
·
Tristan Manalac
Press Releases
InflaRx Reports Third Quarter 2024 Financial Results and Provides Business Update
November 8, 2024
·
19 min read
Press Releases
Kineta Updates KVA12123 Clinical Results from Ongoing Phase 1/2 VISTA101 Study at Society for Immunotherapy of Cancer (2024)
November 8, 2024
·
10 min read
Press Releases
Paratek Pharmaceuticals Announces Positive Top-Line Data from Phase 2b Study of Oral Omadacycline (OMC) in Nontuberculous Mycobacterial (NTM) Abscessus Pulmonary Disease
November 8, 2024
·
7 min read
1 of 83,005
Next
